Insider Transactions in Q4 2021 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2021
|
Paul Sauer SVP Process Dev, Manufacturing |
SELL
Open market or private sale
|
Direct |
6,000
-18.11%
|
$150,000
$25.0 P/Share
|
|
Dec 27
2021
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
51,765
+3.81%
|
$51,765
$1.91 P/Share
|
|
Dec 27
2021
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Direct |
4,750
-22.35%
|
$109,250
$23.83 P/Share
|
|
Dec 27
2021
|
Jeff Fairman VP, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
4,750
+30.33%
|
$4,750
$1.79 P/Share
|
|
Dec 23
2021
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
3,100
-49.8%
|
$74,400
$24.0 P/Share
|
|
Dec 23
2021
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,100
+33.24%
|
$15,500
$5.35 P/Share
|
|
Dec 20
2021
|
Jeff Fairman VP, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
4,469
+29.6%
|
$4,469
$1.79 P/Share
|
|
Dec 16
2021
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Direct |
4,619
-42.85%
|
$101,618
$22.5 P/Share
|
|
Dec 16
2021
|
Jeff Fairman VP, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
4,619
+30.0%
|
$4,619
$1.79 P/Share
|
|
Dec 09
2021
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Direct |
131
-2.08%
|
$2,882
$22.5 P/Share
|
|
Dec 09
2021
|
Jeff Fairman VP, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
131
+2.04%
|
$131
$1.79 P/Share
|
|
Nov 19
2021
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-1.27%
|
$345,000
$23.55 P/Share
|
|
Nov 19
2021
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+2.46%
|
$15,000
$1.79 P/Share
|
|
Nov 18
2021
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
3,100
-25.75%
|
$74,400
$24.85 P/Share
|
|
Nov 18
2021
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,100
+33.24%
|
$15,500
$5.35 P/Share
|
|
Nov 01
2021
|
Paul Sauer SVP Process Dev, Manufacturing |
SELL
Open market or private sale
|
Direct |
3,000
-8.3%
|
$75,000
$25.0 P/Share
|
|
Oct 26
2021
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Direct |
4,750
-48.01%
|
$104,500
$22.69 P/Share
|
|
Oct 26
2021
|
Jeff Fairman VP, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
4,750
+32.44%
|
$4,750
$1.79 P/Share
|
|
Oct 20
2021
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-1.26%
|
$330,000
$22.87 P/Share
|
|
Oct 20
2021
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+2.46%
|
$15,000
$1.79 P/Share
|